Assessment and management of cutaneous reactions with amifostine administration: Findings of the Ethyol (amifostine) Cutaneous Treatment Advisory Panel (ECTAP) [5] (multiple letters)

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 4, 2005, Pages 1279-

  Hicsonmez, Ayse ^a   Andrieu, Meltem Nalca ^a   Akyurek, Serap ^a   Karaca, Metehan ^a   Cagar, Aysun ^a   Ciner, Fuat ^a   Kurtman, Cengiz ^a   Boccia, Ralph ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b Center for Cancer and Blood Disorders   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; RADIOPROTECTIVE AGENT;

ADULT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CELL PROTECTION; DRUG SAFETY; HEAD AND NECK CARCINOMA; HUMAN; HYPOTENSION; LETTER; MALE; PRIORITY JOURNAL; RASH; SIDE EFFECT; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; TOXIC EPIDERMAL NECROLYSIS; VOMITING; BLISTER; CHEMICALLY INDUCED DISORDER; ERYTHEMA MULTIFORME; MIDDLE AGED; NOTE;

AMIFOSTINE; BLISTER; EPIDERMAL NECROLYSIS, TOXIC; ERYTHEMA MULTIFORME; HUMANS; MALE; MIDDLE AGED; RADIATION-PROTECTIVE AGENTS;

EID: 16844369308     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.12.003     Document Type: Letter

References (6)

1. R. Boccia P.R. Anné J. Bourhis Assessment and management of cutaneous reactions with amifostine administration: Findings of the Ethyol (amifostine) Cutaneous Treatment Advisory Panel (ECTAP) Int J Radiat Oncol Biol Phys 60 2004 302 309
2. D.M. Brizel Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma Semin Radiat Oncol 8 1998 237 246
3. M. Al-Sarraf M. LeBlanc P.G. Giri Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317
4. D.M. Brizel T.H. Wasserman H. Henke Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 2000 3339 3345
5. SchuchterLMHensleyMLMeropolNJ 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: Clinical practice guidelines of the American Society of Clinical Oncology J Clin Oncol 20 2002 2895 2903
6. J. Büntzel J. Schuth K. Küttne Radiochemotherapy with amifostine cytoprotection for head and neck cancer Support Care Cancer 6 1998 155 160